MB, Levis & Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.75K Hold
25
– – ﹤0.01% 227
2026
Q2
$1.8K Hold
25
– – ﹤0.01% 233
2026
Q1
$2.96K Hold
25
– – ﹤0.01% 200
2025
Q4
$3.15K Hold
25
– – ﹤0.01% 202
2025
Q3
$3.66K Hold
25
– – ﹤0.01% 195
2025
Q2
$3.9K Hold
25
– – ﹤0.01% 226
2025
Q1
$4.12K Hold
25
– – ﹤0.01% 224
2024
Q4
$4.07K Hold
25
– – ﹤0.01% 228
2024
Q3
$4.88K Buy
+25
New +$4.61K ﹤0.01% 223

Other funds holding ZTS

MB, Levis & Associates's ZTS Position: Q3 2026 in Review

MB, Levis & Associates held its Zoetis (ZTS) position steady in Q3 2026 at 25 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #227.

MB, Levis & Associates first reported a position in ZTS in Q3 2024 and has held it in 9 quarters since. The position peaked at $4.88K in Q3 2024. 1,164 funds tracked by Wall St. Rank hold ZTS as of Q3 2026.

  • MB, Levis & Associates held 25 shares of Zoetis worth $1.75K as of Q3 2026.
  • MB, Levis & Associates left its Zoetis share count unchanged in Q3 2026.
  • Zoetis made up ﹤0.01% of MB, Levis & Associates's portfolio in Q3 2026, its #227 holding.
  • MB, Levis & Associates first reported a position in Zoetis in Q3 2024 and has held it in 9 quarters since.
  • MB, Levis & Associates's Zoetis position peaked at $4.88K in Q3 2024.
  • 1,164 funds tracked by Wall St. Rank held Zoetis as of Q3 2026.

Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.